Mod GRF 1-29 (CJC-1295 No Dac) Nasal Spray

Product Details: Mod GRF 1-29 (CJC-1295 No DAC) (Nasal Spray)

Mod GRF 1-29, also called CJC-1295 No DAC, is a synthetic peptide made from 29 amino acids. It is studied as a growth hormone-releasing hormone (GHRH) analog in laboratory settings.

This is similar to LGD-4033, which has unique characteristics. It may be able to pass through the blood-brain barrier, according to studies. Most of the material that is currently available on this subject comes from studies on animals. These models showed alterations in tissue responsiveness and bone density under controlled settings.

It is also available in lyophilized peptide form for other types of research setups. This product is for laboratory research use only and is not approved for human or veterinary use.

Mechanism of Action

Mod GRF 1-29’s interaction with growth hormone-releasing hormone receptors is investigated in research settings.

In experimental animals, it may affect signaling pathways linked to the release of growth hormone after binding. To comprehend timing, pulse release patterns, and receptor response behavior, these routes are investigated.

It is frequently utilized in studies evaluating the stability and duration of action of different peptide variants due to its shorter structure and lack of DAC modification.

Properties of Mod GRF 1-29

• Molecular Formula: C149H246N44O42
  
• Molecular Weight: 3357.93 g/mol
  
• CAS Number: 86168-78-7
  
• PubChem CID: 16132343
  
• IUPAC Name: L-tyrosyl-L-alanyl-L-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide
  
• Synonyms: Mod GRF 1-29, CJC-1295 No DAC, GRF (1-29)
  

Research Applications

GHRH Receptor Interaction Studies

Mod GRF 1-29 is used to study how peptides bind to GHRH receptors in controlled models. Research focuses on receptor activation and signaling response. [1]

Growth Hormone Signaling Research

Studies examine how this peptide may influence growth hormone-related pathways, including pulse release behavior and timing in experimental systems. [2]

Peptide Stability and Duration Studies

Because it does not include DAC, it is used to compare shorter-acting peptides with extended-release versions. This helps in studying stability and activity duration. [1]

Intranasal Delivery Research

The nasal spray format is included in studies exploring peptide transport through intranasal routes. This supports research on absorption and delivery behavior. [3]

Why Source Mod GRF 1-29 from BehemothLabz

Behemoth Labz has established itself as a reliable and reputable source for research compounds since 2014. We take pride in offering the highest-quality products that are backed by independent, third-party-issued Certificates of Analysis for identification, purity, and concentration.

Our team is committed to quality that extends to every aspect of our business, from same-day processing to free shipping on all orders over $100 and our satisfaction guarantee.

Our team understands the importance of having access to the best compounds for research purposes. 

Our team is dedicated to providing exceptional customer service and ensuring that our customers have access to the compounds they need to conduct groundbreaking research.

Reach out to the support team at support@behemothLabz.com | (307) 429-0990 if you have a question.

Disclaimer: This product is for educational and laboratory research purposes only. It is not intended for human or veterinary use. Product packaging and labeling may be different depending on batch. By placing an order, the customer agrees to the terms and conditions of the company.

References

• Rekasi, Z., et al. Structure and function of GHRH analogs. Endocrine Reviews (2000).
• Bowers, C. Y. Growth hormone-releasing hormone analogs and activity studies. Peptides (1998).
• Illum, L. Intranasal delivery of peptides and proteins. Journal of Controlled Release (2000).